Ishares Pharmaceuticals Etf Price on October 23, 2024
| IHE Etf | USD 68.80 0.34 0.50% |
If you're considering investing in IShares Etf, it is important to understand the factors that can impact its price. As of today, the current price of IShares Pharmaceuticals stands at 68.80, as last reported on the 27th of November, with the highest price reaching 69.14 and the lowest price hitting 68.35 during the day. iShares Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0896, which attests that the entity had a -0.0896% return per unit of risk over the last 3 months. iShares Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IShares Pharmaceuticals' Market Risk Adjusted Performance of (0.50), standard deviation of 0.7293, and Risk Adjusted Performance of (0.07) to validate the risk estimate we provide.
IShares Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
IShares |
Sharpe Ratio = -0.0896
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IHE |
Estimated Market Risk
| 0.73 actual daily | 6 94% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average IShares Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IShares Pharmaceuticals by adding IShares Pharmaceuticals to a well-diversified portfolio.
IShares Pharmaceuticals Valuation on October 23, 2024
It is possible to determine the worth of IShares Pharmaceuticals on a given historical date. On October 23, 2024 IShares was worth 70.82 at the beginning of the trading date compared to the closed value of 70.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of IShares Pharmaceuticals etf. Still, in general, we apply an absolute valuation method to find IShares Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of IShares Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against IShares Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 70.58 | 71.07 | 70.56 | 70.96 | 20,110 | |
10/23/2024 | 70.82 | 71.01 | 70.41 | 70.84 | 28,039 |
| 70.79 | 70.79 | 70.06 | 70.15 | 23,100 |
| Backtest IShares Pharmaceuticals | | | IShares Pharmaceuticals History | | | IShares Pharmaceuticals Valuation | Previous | Next |
IShares Pharmaceuticals Trading Date Momentum on October 23, 2024
| On October 24 2024 iShares Pharmaceuticals ETF was traded for 70.15 at the closing time. Highest IShares Pharmaceuticals's price during the trading hours was 70.79 and the lowest price during the day was 70.06 . The net volume was 23.1 K. The overall trading history on the 24th of October contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 0.97% . The trading date delta to current price is 3.22% . |
iShares Pharmaceuticals Fundamentals Correlations and Trends
By evaluating IShares Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among IShares Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. IShares financial account trend analysis is a perfect complement when working with valuation or volatility modules.About IShares Pharmaceuticals Etf history
IShares Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for IShares is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in iShares Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing IShares Pharmaceuticals stock prices may prove useful in developing a viable investing in IShares Pharmaceuticals
The fund generally will invest at least 80 percent of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. US Pharmaceuticals is traded on NYSEARCA Exchange in the United States.
IShares Pharmaceuticals Etf Technical Analysis
IShares Pharmaceuticals technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Price Boundaries
IShares Pharmaceuticals Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
iShares Pharmaceuticals ETF cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE ARCA Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
IShares Pharmaceuticals November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how IShares Pharmaceuticals etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IShares Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying IShares Pharmaceuticals etf market strength indicators, traders can identify iShares Pharmaceuticals ETF entry and exit signals to maximize returns
IShares Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for IShares Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of IShares Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of IShares to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.19) | |||
| Treynor Ratio | (0.51) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Pharmaceuticals ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
The market value of iShares Pharmaceuticals is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is IShares Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Pharmaceuticals' market value can be influenced by many factors that don't directly affect IShares Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.